{"id":"NCT00076336","sponsor":"Novartis Pharmaceuticals","briefTitle":"Telbivudine Versus Lamivudine in Adults With Decompensated Chronic Hepatitis B and Evidence of Cirrhosis","officialTitle":"Randomized, Double-Blind Trial of Telbivudine Versus Lamivudine in Adults With Decompensated Chronic Hepatitis B and Evidence of Cirrhosis","status":"COMPLETED","phase":"PHASE3","dates":{"start":"2003-12","primaryCompletion":"2009-12","completion":null,"firstPosted":"2004-01-22","resultsPosted":"2011-09-05","lastUpdate":"2011-09-05"},"enrollment":232,"design":{"allocation":"RANDOMIZED","model":"PARALLEL","masking":"QUADRUPLE","primaryPurpose":"TREATMENT"},"conditions":["Hepatitis","Hepatitis B, Chronic","Cirrhosis"],"interventions":[{"type":"DRUG","name":"Telbivudine","otherNames":["LDT600"]},{"type":"DRUG","name":"Lamivudine","otherNames":[]},{"type":"DRUG","name":"Placebo","otherNames":[]}],"arms":[{"label":"Telbivudine 600 mg","type":"EXPERIMENTAL"},{"label":"Lamivudine 100 mg","type":"ACTIVE_COMPARATOR"}],"summary":"This research study was conducted to compare the safety and effectiveness of the investigational medication, LdT (Telbivudine) versus Lamivudine, a drug currently approved by the US, European and Asian Health Authorities for the treatment of Hepatitis B infection. The results for patients taking LdT will be compared to results for patients taking lamivudine.","primaryOutcome":{"measure":"Number of Participants With Clinical Response","timeFrame":"From Baseline to Week 52","effectByArm":[{"arm":"Telbivudine 600 mg","deltaMin":65,"sd":null},{"arm":"Lamivudine 100 mg","deltaMin":62,"sd":null}],"pValues":[]},"eligibility":{"minAge":"16 Years","sex":"ALL","healthyVolunteers":false,"inclusionCount":2,"exclusionCount":4},"locations":{"siteCount":28,"countries":["United States","Australia","Canada","China","France","Germany","India","Israel","Latvia","Malaysia","New Zealand","Poland","Russia","Singapore","South Korea","Spain","Taiwan","Thailand","Turkey (TÃ¼rkiye)","United Kingdom","Vietnam"]},"refs":{"pmids":[],"seeAlso":[]},"adverseEventsSummary":{"seriousAny":{"events":59,"n":115},"commonTop":["Ascites","Oedema peripheral","Abdominal distension","Pyrexia","Gynaecomastia"]}}